
Cataract Surgery Breakthrough: Multifocals vs. The New Accommodating Lenses
What this covers
In this 13-minute solo video, ophthalmologist Dr. Ilan Cohen walks through where cataract lens technology stands and where it is heading. He begins with the anatomy: the natural lens, the capsule that holds it, and the zonules and ciliary muscle that reshape the lens in youth until presbyopia sets in after about 40. He then places accommodating lenses against the two existing categories, monofocals (available for over 50 years) and multifocal lenses (about 15 years). The central contrast is optical. Multifocals split light between zones, which can bring glare and halos, while accommodating designs use all incoming light by mimicking natural focusing.
The middle of the video is a tour of the eight designs now in development. Lumina (Acolens) is CE-marked and in limited European use. Juvine (Lensgen) reports three-year stability. Omniview (Atia Vision) has FDA clearance for U.S. trials. Opira (Foresight) has early two-year results from a mixed monofocal comparison. Alcon's Fluid Vision reached roughly 2.2 diopters of true accommodation. The more exotic entries include the Jelly CIOL, with up to 7 diopters in small early trials, the solid-silicone Acumerix, and the battery-powered liquid-crystal Lensa Sapphire, whose development has slowed. He notes that only about 2.5 diopters are needed for comfortable reading.
The latter part turns cautionary. He lists four predictable first-generation problems: power prediction formulas built for fixed lenses, capsule behavior including capsular fibrosis and tilt of the kind seen as Z syndrome with the older Crystal Lens, demanding sizing and centration, and higher cost and workflow burden. He compares this to the early glare problems of multifocals. His closing guidance is conditional: a mild cataract with comfortable vision can justify waiting, but limits on night driving, work, or safety argue for surgery now.
Dr. Cohen argues that while accommodating intraocular lenses represent a significant technological advance in cataract and vision correction surgery, most patients should not wait for them now because today's multifocal options are mature, well-tested, and excellent—accommodating lenses will arrive in 5–10 years but will require design iterations and carry surgical learning curve risks.
- Eight accommodating lens designs are in development globally; two (Lumina, Juvine, Omniview) are closest to clinical availability but still 5–10 years from broad adoption
- First-generation accommodating lenses will face predictable challenges (power prediction formulas, capsular fibrosis, surgical sizing/centration, workflow costs) similar to early multifocal problems
- Multifocal lenses have proven stable over 15 years and deliver excellent vision for most patients; waiting is only justified if cataracts are mild and vision comfortable
This asset isn't compiled yet
You're seeing its claims, ranked. Compile it to build the argument threads, weight them, and check each claim against your library — the full view.
Accommodating lenses enable the sharpest possible vision without glasses at any distance—distant objects, computer work, or reading—by replicating the natural focusing mechanism of the young eye, using 100% of incoming light instead of splitting it like multifocal lenses, resulting in sharper images, better contrast, and no glares or halos.
“Accommodating lenses enable the sharpest possible vision without glasses at any distance, whether you're viewing distant objects, working on a computer, or reading. These lenses replicate the natural focusing mechanism of the eye when it's young. And like multifocal lenses that split the light between near and distance, accommodating lenses use 100% of the light coming from any object you look at. So the image is sharper, has a better contrast and has none of the dreaded glares or halos.”
Juvine by Lensgen is a two-piece accommodating lens design that fills the capsule and has shown three-year stability in clinical studies, maintaining far, intermediate, and functional near vision while preserving sharp contrast with 100% light at any distance.
“The number one, Juveen by Lensgen. It's a two-piece design that fills the capsule and has already shown three years stability in clinical studies, with patients maintaining far, intermediate, and functional near vision, while keeping sharp contrast with 100% of the light for any distance.”
Fluid Vision by Alcon, studied in the multicentral Orion trial, achieved approximately 2.2 diopters of true accommodation—a measurable improvement in near vision without splitting light—representing a remarkable achievement.
“The next one is Fluid Vision by Alcon. In the multicentral Orion study, patients with this lens gained about 2.2 dioptersof true accommodation, a measurable improvement in near vision without splitting light. That is a remarkable achievement.”
Opira by Foresight Vision, in early 2-year results, showed that patients implanted with Opira in one eye and a standard monofocal in the other reported better near and intermediate vision in the Opira eye while maintaining good distance vision.
“Number 5 is Opira by Foresight Vision. In early 2-year results, patients with an opera lens in one eye and a standard monofocal in the other reported better near and intermediate vision in the opera eye while keeping good distance vision.”
Multifocal lenses split light between distance, intermediate, and near zones; this causes some patients to experience glare and halos, and the quality of vision is not as sharp as it could be if 100% of light from any object were used, making accommodating lenses a better alternative for patients with the strictest vision expectations.
“Because they split the light between distance, intermediate and near. Some patients can experience glare and halos and the quality of the vision is not as good as it could be if we used 100% of the light coming from any given object. For people with the most strict expectations from their vision, the promise of accommodating lenses can offer the best possible alternative.”
Capsular fibrosis can reduce lens motion or tilt the lens over time; older accommodative designs like the Crystal Lens taught the field about Z syndrome (uneven fibrosis causing tilt); modern accommodating lens designs attempt to control or work around capsular behavior, but capsule biology remains a significant consideration.
“The second thing is the capsule behavior. The capsule that the lens sits in can shrink with time. That can reduce motion or tilt a lens. Older accommodative designs like the crystal lens taught us about the Z syndrome, a tiltfrom uneven fibrosis. Modern designs try to control back behavior or work around it. But capsule biology still matters.”
Omniview by Atia Vision received FDA approval for U.S. clinical trials in 2025; early human results showed excellent accuracy and a smooth range of vision, making it one of the most watched designs on the U.S. path to approval.
“The second one is Omniview by Atia Vision. The FDA just approved the U.S. clinical trials in 2025. Early human results showed excellent accuracy and a smooth range of vision, making it one of the most watched designs on the U.S. path.”
Acumerix accommodative lens began first-in-humans study in 2025 in Mexico City; it is a solid silicone design without fluids or electronics, aimed at simplicity and durability.
“Acumerix accommodative lens. A first Inhumans study began in 2025 in Mexico City. This lens is a solid silicone design without fluids or electronics, aiming for simplicity and durability.”
Lumina by Acolens is already approved in Europe (CE mark) and is being implanted in select European centers; a Phase 3 trial reported good distance vision and functional near vision, making Lumina the first accommodating lens patients can actually access today.
“Number 4 is Lumina by Acolens. Lumina is already approved in Europe and is being implanted in select centers. A phase 3 trial reported good distance vision and functional near vision, making it the first accommodating lens patients can actually access today.”
The natural lens is a clear, flexible structure; in youth, muscles surrounding the lens alter its shape to shift focus between distant and near objects; as we age, the lens stiffens, causing presbyopia (typically after age 40) that makes clear up-close vision difficult without reading glasses.
“Your natural lens is a clear flexible structure inside the eye. In our youth, the muscles surrounding the lens are able to alter its shape, allowing us to shift our focus between distant and near objects. As we age, our natural lens stiffens, making it difficult to focus as it once did. This process, known as presbyopia, typically begins after the age of 40, and makes clear up-close vision challenging without reading glasses.”
Currently, 8 major accommodating lens designs are in development globally, each supported by a different company and using a distinct mechanical or optical approach.
“Currently, 8 major accommodating lens designs are in development globally. Each design is supported by a different company and uses a distinct approach.”
Lumina from Acolens is the accommodating lens most likely to reach patients soonest because it already has CE mark approval and is in limited clinical use in Europe today.
“The lens most likely to reach patients soonest is the Lumina from ACO lens because it already has a CE mark approval and is in limited use in Europe today.”
Monofocal lenses have been available for more than 50 years and can provide good vision if patients don't mind wearing reading glasses; multifocal lenses became available in the last 15 years and revolutionized outcomes for patients wanting freedom from glasses for both reading and distance vision.
“Monofocal lenses have been available for more than 50 years and can provide good vision if you don't mind wearing reading glasses. Multifocal lenses have become available in the last 15 years and have revolutionized the outcome for patients who want to be free of glasses both for reading and for far vision.”
Only 2.5 diopters of accommodation are needed for perfect reading; therefore, achieving 2.2 diopters (Fluid Vision) or 7 diopters (Jelly CIOL) would be sufficient or far exceed the functional requirement.
“This is an absolutely remarkable outcome when you take into account that we only need two and a half diopters of accommodation to read perfectly.”
The lens capsule is a thin, clear bag that holds the natural lens; it is attached via tiny zonule strings to the ciliary muscle inside the eye; during cataract surgery, the surgeon removes the clouded lens nucleus through a circular opening in the front but leaves the capsule intact to support the new implant.
“These lenses sit in our natural lens capsule. What is a capsule? The capsule is simply a thin, clear bag that holds our natural lens. This capsule is attached with tiny little strings called zonules to a muscle inside the eye known as the ciliary muscle. During cataract surgery, the surgeon removes the clavulans through a circular opening in the front but leaves this bag otherwise intact to support the new implant.”
Jelly CIOL, in small early human trials, achieved up to 7 diopters of accommodative change at one year—an absolutely remarkable outcome given that only 2.5 diopters of accommodation are needed for perfect reading; developers believe capsular fibrosis, which typically impairs accommodation in other designs, may actually enhance performance in this design.
“Number 6 is Jelly CIOL. In a small early human trials, patients gained up to 7 diopters of accommodative changeat one year. This is an absolutely remarkable outcome when you take into account that we only need two and a half diopters of accommodation to read perfectly. Also, the developers believe that the capsular fibrosis, which usually hurts accommodation, may actually enhance performance here.”
Lensa Sapphire autofocal lens uses a liquid crystal element powered by a rechargeable microbattery to change focus electronically; development has slowed, but it remains one of the most futuristic design ideas.
“Number eight is a Lensa Sapphire autofocal lens. This design uses a liquid crystal element powered by a rechargeable microbattery to change focus electronically. Development slowed, but it remains one of the most futuristic ideas.”
Early accommodating lenses will predictably encounter four main issues: (1) power prediction—accommodating lenses shift shape, making current formulas (designed for fixed lenses) inaccurate, requiring new formula development; (2) capsule behavior—the capsule can shrink with time, reducing lens motion or tilting it (e.g., Z syndrome from uneven fibrosis); (3) sizing and centration—lenses demand perfect capsule sizing and centering, and misalignment blunts their effect and steepens surgical learning curve; (4) workflow and cost—more extensive surgical cuts, multiple appointments, new tools, team training, and higher initial device costs with frequent checkups.
“Early accommodating lenses will predictively encounter four main issues. Number one is the power prediction. Our lens formulas today assume a lens sits still. A moving, shape-shifting lens makes the calculations significantly more challenging. It will take time to develop new formulas that match these lenses. The second thing is the capsule behavior. The capsule that the lens sits in can shrink with time. That can reduce motion or tilt a lens. Older accommodative designs like the crystal lens taught us about the Z syndrome, a tiltfrom uneven fibrosis. Modern designs try to control back behavior or work around it. But capsule biology still matters. The third issue is the sizing and centration of the capsule axis. These lenses demand a perfectly sized and centered opening. Too tight or off-center can blunt the effect. This increases the surgical challenge and steepens the learning curve for the surgeon. The fourth issue is the workflow and cost. Potential challenges include more extensive cuts requiring two separate appointments,the acquisition of new tools, and additional team training. Initially, new devices will incur significantly higher costs, and more frequent checkups will be necessary during the transition period.”
Multifocal lenses are an excellent choice for cataract surgery because they have stood the test of time over 15 years; many patients already enjoy excellent vision outcomes with them; today's multifocal options provide excellent results when matched to the right patient eye and performed with proper surgical technique.
“Multifocals are an excellent choice, they have stood the test of time and many people are already enjoying their vision with them. Today's options already provide excellent outcomes when matched to the right eye and performed correctly.”
Accommodating lenses demand a perfectly sized and centered capsular opening; if the opening is too tight or off-center, it blunts the accommodating effect; this increases surgical difficulty and steepens the learning curve for surgeons adopting the technology.
“The third issue is the sizing and centration of the capsule axis. These lenses demand a perfectly sized and centered opening. Too tight or off-center can blunt the effect. This increases the surgical challenge and steepens the learning curve for the surgeon.”
Accommodating lens formulas will be significantly more challenging to develop than current formulas because today's formulas assume a lens sits in a fixed position, whereas accommodating lenses move and shift shape, requiring new mathematical models to accurately predict their in-eye behavior.
“Number one is the power prediction. Our lens formulas today assume a lens sits still. A moving, shape-shifting lens makes the calculations significantly more challenging. It will take time to develop new formulas that match these lenses.”
Accommodating lens surgery will involve more extensive surgical cuts, may require two separate appointments, necessitates acquisition of new surgical tools, and requires additional team training; initially, new accommodating lens devices will incur significantly higher costs, and patients will require more frequent checkups during the transition period.
“The fourth issue is the workflow and cost. Potential challenges include more extensive cuts requiring two separate appointments,the acquisition of new tools, and additional team training. Initially, new devices will incur significantly higher costs, and more frequent checkups will be necessary during the transition period.”
If a cataract is mild and vision is comfortable, waiting for accommodating lenses is reasonable; however, if night driving, work performance, or safety are already limited by cataracts, it is time to pursue cataract surgery now with currently available options.
“If your cataract is mild and your vision is comfortable, waiting is fine. However, if night driving, work or safety are already limited, it's time to consider the excellent options available today.”
Early multifocal lenses had issues with glare and halos, which later versions largely corrected; a similar progression should be expected with accommodating lenses—early designs will encounter predictable issues that later generations will resolve.
“The first and even second generation of a new lens technology are usually not perfect. They require significant modifications. Early multifocal lenses, for example, had issues with glare and halos, which later versions largely corrected. Expect a similar progression here.”
If early-generation accommodating lenses require fixes (as they almost certainly will, following the pattern of early multifocal lenses), second-generation designs will come quickly, just as improved multifocal designs emerged rapidly.
“I'll keep tracking the data. If the first wave needs fixes, as it almost always does, second generation designs will come fast, just as they did with the multifocal lenses.”
Based on clinical results so far, Juvine and Omniview stand out as the most promising accommodating lenses because they preserve superb clarity while adding continuous range of focus; both are advancing through U.S. clinical trials, making them strong contenders for broad use in the next 5 to 10 years.
“And the most promising? Based on clinical results so far, the Juvine and the Omniview stand out. They preserve superb clarity while adding a continuous range of focus and both are advancing through US clinical trials. making them strong contenders for broad use in the next 5 to 10 years.”
Dr. Cohen will publicly communicate when an accommodating lens has proven it can deliver clear distance vision, comfortable near vision, stable power over time, and low night symptoms in regular patient populations (not just in trials); at that point, he will specify which lens design it is and which patients it is suited for.
“When a lens proves that it can deliver clear distance, comfortable near vision, Stable power and low night symptoms in regular patients, not just in trials. I'll say so here and I'll tell you who it's for.”
Dr. Cohen has performed tens of thousands of eye surgeries over 25 years of practice as a board-certified cataract and premium lens surgeon.
“Hi, I'm Dr. Ilan Cohen, a board-certified cataract and premium lens surgeon. After 25 years and tens of thousands of eye surgeries, I'll take you inside the promise and the reality of this next big leap in vision correction and cataract surgery.”
Unlike the natural young lens, which is flexible and can actively change shape to focus, an artificial intraocular lens cannot move inside the eye and sits in a fixed position.
“But unlike our natural young lens, which is flexible and can actively change its shape in order to focus, this artificial lens cannot move inside the eye and sits in a fixed position.”
During cataract surgery, the surgeon replaces the clouded natural lens with an artificial intraocular lens (IOL) implant, which stays in place permanently and restores clear vision.
“During cataract surgery, the surgeon replaces this lens with an artificial implant called an intraocular lens. This lens stays in place permanently and restores clear vision.”
The natural lens in youth has flexibility; this flexibility enables accommodation (the ability to shift focus between near and distant objects).
“In our youth, the muscles surrounding the lens are able to alter its shape, allowing us to shift our focus between distant and near objects.”
Presbyopia typically begins after age 40 and makes clear up-close vision challenging without reading glasses.
“This process, known as presbyopia, typically begins after the age of 40, and makes clear up-close vision challenging without reading glasses.”
Later in life, the lens can lose its clarity and become cloudy, a condition called cataract.
“Later in life, the lens can also lose its clarity becoming cloudy, a condition called cataract.”
The video promises to provide a realistic outlook on accommodating lens technology by the end, enabling viewers to decide whether waiting for this technology is justified for their situation.
“Stick around because by the end of this video you will have a very realistic outlook of this technology and can decide if waiting is justified for you.”
The video is intended for anyone considering cataract surgery or lens replacement surgery for vision correction and who is contemplating whether to wait for accommodating lenses or proceed with current technology.
“It's for anyone who has a cataract or anyone who considers lens replacement surgery for vision correction. If you were wondering whether you should have your cataract surgery now or wait for this much anticipated technology, this video is for you.”
Dr. Cohen invites patients to visit his office or schedule a virtual consultation to determine which lens is right for their eyes; for out-of-state patients, he has designed a special program enabling testing, consultation, and surgical planning in a single streamlined visit, eliminating the need for multiple trips.
“Finally, if you'd like to know which lens is right for your eyes. I invite you to come see me in my office or schedule a virtual consultation, if that's easier. For patients traveling from out of state, we've designed a special program so everything can be done in a single streamlined visit. That means your testing, consultation and surgical planning are completed the same day, so you won't need to make multiple trips.”